300119 瑞普生物
按盤價 
15.080 +1.610 (+11.952%)
15.080 +1.610 (+11.952%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 3.552 | 10.391 | 8.401 | 12.724 | 17.398 |
| 總資產報酬率 ROA (%) | 2.308 | 7.132 | 5.878 | 8.609 | 10.672 |
| 投入資產回報率 ROIC (%) | 2.754 | 8.316 | 6.800 | 10.137 | 13.067 | 邊際利潤分析 |
| 銷售毛利率 (%) | 48.519 | 49.687 | 48.441 | 51.804 | 54.040 |
| 營業利潤率 (%) | 17.204 | 25.133 | 19.990 | 24.879 | 25.651 |
| 息稅前利潤/營業總收入 (%) | 18.076 | 26.040 | 20.686 | 25.238 | 26.818 |
| 淨利潤/營業總收入 (%) | 15.269 | 22.722 | 17.933 | 21.602 | 21.970 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 89.625 | 66.110 | 85.140 | 72.810 | 79.075 |
| 價值變動淨收益/利潤總額(%) | 8.781 | 13.484 | 13.396 | 27.115 | 23.146 |
| 營業外收支淨額/利潤總額(%) | -0.409 | 0.256 | -0.683 | -2.372 | -0.431 | 償債能力分析 |
| 流動比率 (X) | 1.805 | 2.426 | 2.362 | 2.724 | 1.829 |
| 速動比率 (X) | 1.574 | 2.137 | 2.081 | 2.404 | 1.414 |
| 資產負債率 (%) | 32.142 | 27.154 | 26.287 | 24.024 | 0.298 |
| 帶息債務/全部投入資本 (%) | 21.305 | 17.974 | 17.485 | 15.519 | 17.139 |
| 股東權益/帶息債務 (%) | 354.700 | 442.670 | 460.543 | 524.461 | 449.265 |
| 股東權益/負債合計 (%) | 192.994 | 251.042 | 262.994 | 294.971 | 211.284 |
| 利息保障倍數 (X) | 19.195 | 30.920 | 24.855 | 26.968 | 20.992 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 158.521 | 134.895 | 113.600 | 91.101 | 71.166 |
| 存貨周轉天數 (天) | 124.632 | 120.421 | 121.862 | 134.805 | 122.881 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 30/09/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
